TSN
50
-2
GS
72
4
MU
28
-3
AIZ
82
2
EA
60
-5
AXP
67
-2
KMX
61
-3
CMS
60
2
GD
41
-4
KHC
9
-4
SWKS
38
-2
PEP
39
-9
COST
57
-6
CMA
61
-3
AON
54
2
RL
69
-4
KMI
69
-2
ETR
65
2
DFS
64
2
WDC
37
-3
TSN
50
-2
GS
72
4
MU
28
-3
AIZ
82
2
EA
60
-5
AXP
67
-2
KMX
61
-3
CMS
60
2
GD
41
-4
KHC
9
-4
SWKS
38
-2
PEP
39
-9
COST
57
-6
CMA
61
-3
AON
54
2
RL
69
-4
KMI
69
-2
ETR
65
2
DFS
64
2
WDC
37
-3
Financhill
Back

Regeneron Pharmaceuticals Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
38

REGN
Regeneron Pharmaceuticals

Last Price:
756.26
Seasonality Move:
14.2%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
38
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $756.81. The Score for REGN is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $756.81
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -59.96 Sell
Relative Strength Index (14 RSI): 11.99 Sell
Chaikin Money Flow: -1080732 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (813.45 - 975.23) Sell
Bollinger Bands (100): (938.37 - 1159.25) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 807.49 Sell
20-day SMA: 865.64 Sell
50-day SMA: 987.9 Sell
200-day SMA: 1006.29 Sell
8-day EMA: 805.73 Sell
20-day EMA: 861.1 Sell
50-day EMA: 950.35 Sell
200-day EMA: 985.12 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.38 per share, and an increase next year of $0.57 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):